A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, Both With Insulin Aspart as Mealtime Insulin in Subjects With Type 1 Diabetes
Completed · Phase 3
Conditions studied: Diabetes, Diabetes Mellitus, Type 1
In brief
This trial is conducted in Europe and the United States of America (USA). The aim of the trial is to compare the safety and efficacy of insulin degludec (IDeg) and insulin glargine (IGlar), both with insulin aspart (IAsp) as mealtime insulin in subjects with type 1 diabetes.
Key facts
- Study ID
- NCT02034513
- Run by
- Novo Nordisk A/S
- People needed
- 501
- Starts
- 2014-01-05
- Expected to finish
- 2016-01-11
- Last updated by the study team
- 2019-01-02
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Novo Nordisk Investigational Site — Goodyear, Arizona, United States
- Novo Nordisk Investigational Site — Concord, California, United States
- Novo Nordisk Investigational Site — Escondido, California, United States
- Novo Nordisk Investigational Site — Fresno, California, United States
- Novo Nordisk Investigational Site — La Jolla, California, United States
- Novo Nordisk Investigational Site — Long Beach, California, United States
- Novo Nordisk Investigational Site — Rancho Cucamonga, California, United States
- Novo Nordisk Investigational Site — San Mateo, California, United States
- Novo Nordisk Investigational Site — San Ramon, California, United States
- Novo Nordisk Investigational Site — Santa Monica, California, United States
- Novo Nordisk Investigational Site — Upland, California, United States
- Novo Nordisk Investigational Site — Ventura, California, United States
- Novo Nordisk Investigational Site — Denver, Colorado, United States
- Novo Nordisk Investigational Site — Cooper City, Florida, United States
- Novo Nordisk Investigational Site — Fleming Island, Florida, United States
- Novo Nordisk Investigational Site — Fort Lauderdale, Florida, United States
- Novo Nordisk Investigational Site — Hialeah, Florida, United States
- Novo Nordisk Investigational Site — Jacksonville, Florida, United States
- Novo Nordisk Investigational Site — Jacksonville, Florida, United States
- Novo Nordisk Investigational Site — Jacksonville, Florida, United States
- Novo Nordisk Investigational Site — Jacksonville, Florida, United States
- Novo Nordisk Investigational Site — Miami, Florida, United States
- Novo Nordisk Investigational Site — Miami, Florida, United States
- Novo Nordisk Investigational Site — Miami, Florida, United States
- Novo Nordisk Investigational Site — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.